James A. Allay

5.1k total citations
20 papers, 1.4k citations indexed

About

James A. Allay is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, James A. Allay has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in James A. Allay's work include Virus-based gene therapy research (14 papers), RNA Interference and Gene Delivery (6 papers) and CRISPR and Genetic Engineering (5 papers). James A. Allay is often cited by papers focused on Virus-based gene therapy research (14 papers), RNA Interference and Gene Delivery (6 papers) and CRISPR and Genetic Engineering (5 papers). James A. Allay collaborates with scholars based in United States, United Kingdom and Ireland. James A. Allay's co-authors include Derek A. Persons, Arthur W. Nienhuis, Brian P. Sorrentino, Richard A. Ashmun, Esther R. Allay, Janice M. Riberdy, Raymond L. Blakley, Richard J. Smeyne, John M. Cunningham and Donald Orlic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Blood.

In The Last Decade

James A. Allay

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Allay United States 15 936 689 347 258 216 20 1.4k
Guillermo Güenechea Spain 20 1.3k 1.4× 586 0.9× 340 1.0× 286 1.1× 438 2.0× 42 1.9k
Yasuji Ueda Japan 21 788 0.8× 537 0.8× 304 0.9× 112 0.4× 90 0.4× 73 1.4k
Sally E. Spence United States 17 761 0.8× 425 0.6× 201 0.6× 132 0.5× 260 1.2× 26 1.2k
Johannes C.M. van der Loo United States 18 868 0.9× 731 1.1× 418 1.2× 176 0.7× 384 1.8× 32 1.7k
Tobias Maetzig Germany 22 1.7k 1.8× 1.2k 1.7× 489 1.4× 122 0.5× 133 0.6× 47 2.1k
Glenn P. Niemeyer United States 13 387 0.4× 454 0.7× 207 0.6× 232 0.9× 202 0.9× 24 984
Christel Rivière France 11 520 0.6× 454 0.7× 144 0.4× 182 0.7× 158 0.7× 13 967
Gaby Brouns Netherlands 13 851 0.9× 671 1.0× 346 1.0× 185 0.7× 120 0.6× 17 1.5k
Francesca Ficara Italy 16 1.2k 1.3× 786 1.1× 633 1.8× 160 0.6× 316 1.5× 43 1.9k
Pervin Anklesaria United States 22 1.0k 1.1× 385 0.6× 486 1.4× 297 1.2× 611 2.8× 56 2.1k

Countries citing papers authored by James A. Allay

Since Specialization
Citations

This map shows the geographic impact of James A. Allay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Allay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Allay more than expected).

Fields of papers citing papers by James A. Allay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Allay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Allay. The network helps show where James A. Allay may publish in the future.

Co-authorship network of co-authors of James A. Allay

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Allay. A scholar is included among the top collaborators of James A. Allay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Allay. James A. Allay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allay, James A., Susan Sleep, David M. Tillman, et al.. (2011). Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial. Human Gene Therapy. 22(5). 595–604. 115 indexed citations
2.
3.
Allay, James A., Jacques Galipeau, Raymond L. Blakley, & Brian P. Sorrentino. (2009). Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells. Stem Cells. 16(S2). 223–233. 3 indexed citations
4.
5.
Weld, Kyle J., James A. Allay, Chris Reed, et al.. (2002). Transrectal gene therapy of the prostate in the canine model. Cancer Gene Therapy. 9(2). 189–196. 3 indexed citations
6.
Leimig, Thasia, Linda Männ, Maria del Pilar Martin, et al.. (2002). Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood. 99(9). 3169–3178. 57 indexed citations
7.
Allay, James A., et al.. (2000). Adenovirus p16 gene therapy for prostate cancer. World Journal of Urology. 18(2). 111–120. 29 indexed citations
8.
Patel, Divyen H., James A. Allay, J A Belt, & Brian P. Sorrentino. (2000). Retroviral transfer of the hENT2 nucleoside transporter cDNA confers broad-spectrum antifolate resistance in murine bone marrow cells. Blood. 95(7). 2356–2363. 11 indexed citations
9.
Donahue, Robert E., Robert P. Wersto, James A. Allay, et al.. (2000). High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34+ cells. Blood. 95(2). 445–452. 45 indexed citations
10.
Patel, Divyen H., James A. Allay, J A Belt, & Brian P. Sorrentino. (2000). Retroviral transfer of the hENT2 nucleoside transporter cDNA confers broad-spectrum antifolate resistance in murine bone marrow cells. Blood. 95(7). 2356–2363. 1 indexed citations
11.
Allay, James A., Derek A. Persons, Phillip W. Hargrove, et al.. (1999). High-Efficiency Transduction and Long-Term Gene Expression with a Murine Stem Cell Retroviral Vector Encoding the Green Fluorescent Protein in Human Marrow Stromal Cells. Human Gene Therapy. 10(7). 1163–1173. 98 indexed citations
12.
Persons, Derek A., James A. Allay, Esther R. Allay, et al.. (1999). Enforced Expression of the GATA-2 Transcription Factor Blocks Normal Hematopoiesis. Blood. 93(2). 488–499. 15 indexed citations
13.
Persons, Derek A., James A. Allay, Esther R. Allay, et al.. (1999). Enforced Expression of the GATA-2 Transcription Factor Blocks Normal Hematopoiesis. Blood. 93(2). 488–499. 199 indexed citations
14.
Allay, James A., Derek A. Persons, Jacques Galipeau, et al.. (1998). In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Medicine. 4(10). 1136–1143. 175 indexed citations
15.
Persons, Derek A., James A. Allay, Janice M. Riberdy, et al.. (1998). Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells. Nature Medicine. 4(10). 1201–1205. 93 indexed citations
16.
Allay, James A., James E. Dennis, Stephen E. Haynesworth, et al.. (1997). LacZ and Interleukin-3 Expression In Vivo after Retroviral Transduction of Marrow-Derived Human Osteogenic Mesenchymal Progenitors. Human Gene Therapy. 8(12). 1417–1427. 131 indexed citations
17.
Allay, James A., et al.. (1997). Sensitization of Hematopoietic Stem and Progenitor Cells to Trimetrexate Using Nucleoside Transport Inhibitors. Blood. 90(9). 3546–3554. 61 indexed citations
18.
19.
Koç, Omer N., et al.. (1996). Role of DNA Repair in Resistance to Drugs that Alkylate O6 of Guanine. Cancer treatment and research. 87. 123–146. 10 indexed citations
20.
Reese, Jane, et al.. (1996). Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O 6 -benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea. Proceedings of the National Academy of Sciences. 93(24). 14088–14093. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo Güenechea Breakdown of academic impact, for papers by Yasuji Ueda Breakdown of academic impact, for papers by Sally E. Spence Breakdown of academic impact, for papers by Johannes C.M. van der Loo Breakdown of academic impact, for papers by Tobias Maetzig Breakdown of academic impact, for papers by Glenn P. Niemeyer Breakdown of academic impact, for papers by Christel Rivière Breakdown of academic impact, for papers by Gaby Brouns Breakdown of academic impact, for papers by Francesca Ficara Breakdown of academic impact, for papers by Pervin Anklesaria
Rankless by CCL
2026